Green Jeremy
Insider CIK 1650527 · ARRY 10% owner · FOLD 10% owner · VAPO 10% owner · XERS 10% owner · MDVL Director, 10% owner · NLTX 10% owner · ALDR Director, 10% owner · FATE Director, 10% owner · IGMS Director, 10% owner · ANNX 10% owner · BCEL 10% owner · NRIX 10% owner · SYRS 10% owner · ALLK 10% owner · ATRA Director · STOK 10% owner · GRTS 10% owner · ABSI Director, 10% owner · STTK Director, 10% owner · TRDA 10% owner · REPL 10% owner · AKRO 10% owner · BEAM 10% owner · PLRX 10% owner · TCRR 10% owner · ALVR 10% owner · CABA 10% owner · HOOK 10% owner · AUGX Director, 10% owner · ADCT 10% owner · APRE 10% owner · RPTX 10% owner · KYMR 10% owner · SNCE Director, 10% owner · RYZB 10% owner · ADGI 10% owner · VERV 10% owner · ZYME 10% owner · ATTO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATTO Attovia Therapeutics, Inc. | C Conversion deriv | 2026-08-06 | 2026-08-07 | 782,854 | — | $0 | 0 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | P Buy | 2026-08-06 | 2026-08-07 | 400,000 | $17.00 | $6.80M | 1,182,854 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion | 2026-08-06 | 2026-08-07 | 782,854 | — | $0 | 782,854 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | P Buy | 2026-08-06 | 2026-08-07 | 200,000 | $17.00 | $3.40M | 982,854 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion deriv | 2026-08-06 | 2026-08-07 | 782,854 | — | — | 0 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | P Buy | 2026-08-06 | 2026-08-07 | 400,000 | $17.00 | $6.80M | 1,182,854 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | P Buy | 2026-08-06 | 2026-08-07 | 200,000 | $17.00 | $3.40M | 982,854 | SEC↗ |
| ATTO Attovia Therapeutics, Inc. | C Conversion | 2026-08-06 | 2026-08-07 | 782,854 | — | — | 782,854 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2026-07-22 | 2026-07-24 | 101,089 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2026-07-22 | 2026-07-24 | 38,735 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2026-07-22 | 2026-07-24 | 55,387 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2026-07-22 | 2026-07-24 | 195,211 | — | $0 | 636,912 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2026-07-22 | 2026-07-24 | 60 | — | $0 | 636,852 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2026-06-12 | 2026-06-15 | 87,900 | — | $0 | 87,900 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 266,280 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 162,013 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 266,280 | — | $0 | 502,769 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 162,013 | — | $0 | 2,755,086 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 3,691,324 | — | $0 | 3,893,674 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-22 | 3,691,324 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-23 | 266,280 | — | $0 | 502,769 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2026-04-20 | 2026-04-23 | 266,280 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2026-04-20 | 2026-04-22 | 8,977,624 | — | $0 | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2026-04-20 | 2026-04-22 | 8,977,624 | — | $0 | 12,884,277 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-02 | 2026-04-02 | 2,529,491 | $3.28 | $8.30M | 10,265,297 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-02 | 2026-04-02 | 2,634,506 | $3.28 | $8.64M | 12,666,731 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-01 | 2026-04-02 | 169,265 | $3.80 | $643.2K | 15,301,237 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-04-01 | 2026-04-02 | 162,517 | $3.80 | $617.6K | 12,794,788 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-03-31 | 2026-04-02 | 188,407 | $3.75 | $706.5K | 12,957,305 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2026-03-31 | 2026-04-02 | 196,229 | $3.75 | $735.9K | 15,470,502 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-10-27 | 2025-10-28 | 3,846,153 | $3.90 | $15.00M | 3,846,153 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-10-27 | 2025-10-28 | 3,846,153 | $3.90 | $15.00M | 3,846,153 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2025-08-25 | 2025-08-26 | 4,097,730 | — | $0 | 4,097,730 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2025-08-25 | 2025-08-26 | 4,097,730 | — | $0 | 7,198,553 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer deriv | 2025-08-14 | 2025-08-15 | 7,199,325 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer deriv | 2025-08-14 | 2025-08-15 | 667,666 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer | 2025-08-14 | 2025-08-15 | 2,964,843 | — | $0 | 0 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2025-07-14 | 2025-07-16 | 33,150 | — | $0 | 33,150 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2025-06-30 | 2025-07-02 | 828 | — | $0 | 2,964,843 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-06-11 | 2025-06-13 | 15,734,267 | $3.43 | $53.97M | 15,734,267 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2025-06-11 | 2025-06-13 | 12,465,234 | $3.43 | $42.76M | 12,465,234 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-05-29 | 2025-05-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2025-03-31 | 2025-04-02 | 828 | — | $0 | 2,964,015 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-12-31 | 2025-01-02 | 1,734 | — | $0 | 2,963,187 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2024-12-20 | 2024-12-26 | 56,331 | $1.68 | $94.6K | 502,769 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2024-12-20 | 2024-12-26 | 116,261 | $8.40 | $976.6K | 2,755,086 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2024-12-20 | 2024-12-26 | 116,261 | $8.40 | $976.6K | 2,638,825 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2024-12-20 | 2024-12-26 | 397,964 | $1.68 | $668.6K | 12,884,277 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2024-12-20 | 2024-12-26 | 1,084,936 | $1.68 | $1.82M | 11,743,010 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2024-12-20 | 2024-12-26 | 1,084,936 | $1.68 | $1.82M | 12,827,946 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2024-12-20 | 2024-12-26 | 341,633 | $1.68 | $573.9K | 12,486,313 | SEC↗ |
| FATE FATE THERAPEUTICS INC | C Conversion deriv | 2024-12-12 | 2024-12-16 | 6,022 | — | $0 | 2,755,086 | SEC↗ |
| FATE FATE THERAPEUTICS INC | C Conversion | 2024-12-12 | 2024-12-16 | 30,110 | — | $0 | 12,827,946 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $3.81 | $190.5K | 15,666,731 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $3.81 | $190.5K | 13,145,712 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $2.28 | $114.0K | 15,616,731 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-12-11 | 2024-12-13 | 50,000 | $2.28 | $114.0K | 13,095,712 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 8,136,609 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 8,163,265 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-12-04 | 2024-12-06 | 26,656 | $2.07 | $55.2K | 6,133,837 | SEC↗ |
| STTK Shattuck Labs, Inc. | S Sale | 2024-12-04 | 2024-12-06 | 133,371 | $1.25 | $166.7K | 5,406,353 | SEC↗ |
| STTK Shattuck Labs, Inc. | J Other | 2024-12-04 | 2024-12-06 | 1,026,888 | $1.25 | $1.28M | 5,539,724 | SEC↗ |
| STTK Shattuck Labs, Inc. | J Other | 2024-12-04 | 2024-12-06 | 1,026,888 | $1.25 | $1.28M | 4,512,836 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2024-12-04 | 2024-12-06 | 133,371 | $1.25 | $166.7K | 5,539,724 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 13,045,712 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 15,516,059 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other | 2024-12-04 | 2024-12-06 | 50,672 | $2.07 | $104.9K | 15,566,731 | SEC↗ |
| ADCT ADC Therapeutics SA | S Sale | 2024-12-04 | 2024-12-06 | 25,352 | $2.07 | $52.5K | 15,566,731 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 1,093,799 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 1,093,799 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 3,125,195 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer deriv | 2024-10-02 | 2024-10-04 | 3,125,195 | — | $0 | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 9,446,146 | $2.35 | $22.20M | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 6,218,238 | $2.35 | $14.61M | 0 | SEC↗ |
| AUGX Augmedix, Inc. | D To issuer | 2024-10-02 | 2024-10-04 | 16,421,788 | $2.35 | $38.59M | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-09-30 | 2024-10-02 | 1,734 | — | $0 | 3,081,800 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-07-01 | 2024-07-03 | 400,000 | $2.81 | $1.12M | 15,669,217 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy | 2024-07-01 | 2024-07-03 | 400,000 | $2.81 | $1.12M | 12,995,040 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,734 | — | $0 | 3,080,066 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 27,700 | — | $0 | 27,700 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2024-06-14 | 2024-06-18 | 12,879 | — | $0 | 16,421,788 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 36,274 | — | $0 | 36,274 | SEC↗ |
| ABSI Absci Corp | A Award | 2024-06-12 | 2024-06-14 | 8,820 | — | $0 | 8,262,136 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-05-08 | 2024-05-10 | 6,107,181 | $4.81 | $29.38M | 6,107,181 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-05-08 | 2024-05-10 | 8,163,265 | $4.81 | $39.27M | 8,163,265 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-03-29 | 2024-04-01 | 1,734 | — | $0 | 3,078,332 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other | 2024-03-28 | 2024-04-01 | 12,464 | — | $0 | 3,076,598 | SEC↗ |
| STTK Shattuck Labs, Inc. | J Other | 2024-03-28 | 2024-04-01 | 4,425 | — | $0 | 5,615,489 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-03-21 | 2024-03-25 | 3,636,364 | $5.50 | $20.00M | 3,893,674 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2024-03-15 | 2024-03-19 | 3,125 | — | $0 | 16,408,909 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | D To issuer deriv | 2024-03-12 | 2024-03-13 | 95,765 | — | $0 | 0 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | D To issuer deriv | 2024-03-12 | 2024-03-13 | 2,068 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 29,400 | — | $0 | 29,400 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | U Tender | 2024-03-12 | 2024-03-13 | 1,017,203 | $5.75 | $5.85M | 0 | SEC↗ |
| ABSI Absci Corp | P Buy | 2024-03-01 | 2024-03-05 | 222,222 | $4.50 | $1000.0K | 8,253,316 | SEC↗ |
| IGMS IGM Biosciences, Inc. | C Conversion deriv | 2024-02-28 | 2024-03-01 | 113,400 | — | $0 | 7,199,325 | SEC↗ |
| IGMS IGM Biosciences, Inc. | C Conversion | 2024-02-28 | 2024-03-01 | 113,400 | — | $0 | 3,089,062 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-07 | 2024-02-09 | 107,590 | — | $0 | 107,590 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-02 | 2024-02-09 | 144,517 | — | $0 | 144,517 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-02 | 2024-02-09 | 11,159 | — | $0 | 11,159 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-02-01 | 2024-02-09 | 19,700 | $3.38 | $66.6K | 1,180,136 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-01 | 2024-02-09 | 205,483 | — | $0 | 205,483 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-02-01 | 2024-02-09 | 15,867 | — | $0 | 15,867 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-31 | 2024-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-30 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-29 | 2024-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-26 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-25 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-24 | 2024-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-16 | 2024-02-09 | 53,900 | — | $0 | 53,900 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-12 | 2024-02-09 | 93,424 | — | $0 | 93,424 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-11 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-10 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-09 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-08 | 2024-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-05 | 2024-02-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-04 | 2024-02-09 | 28,652 | — | $0 | 28,652 | SEC↗ |
| ADCT ADC Therapeutics SA | J Other deriv | 2024-01-03 | 2024-02-09 | 59,986 | $1.68 | $100.8K | 1,199,836 | SEC↗ |
| ADCT ADC Therapeutics SA | P Buy deriv | 2024-01-03 | 2024-02-09 | 56,900 | — | $0 | 56,900 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-12-29 | 2024-01-03 | 492 | — | $0 | 2,975,662 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2023-12-26 | 2023-12-28 | 1,655,370 | $3.72 | $6.16M | 13,135,758 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2023-12-26 | 2023-12-28 | 1,655,370 | $3.72 | $6.16M | 13,135,758 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-12-26 | 2023-12-28 | 44,630 | $3.72 | $166.0K | 13,180,388 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2023-12-21 | 2023-12-26 | 3,100,823 | — | $0 | 3,100,823 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2023-12-15 | 2023-12-19 | 1,767 | — | $0 | 16,405,784 | SEC↗ |
| AUGX Augmedix, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 1,093,799 | — | $0 | 1,093,799 | SEC↗ |
| AUGX Augmedix, Inc. | A Award deriv | 2023-11-20 | 2023-11-22 | 1,093,799 | — | $0 | 1,093,799 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 750,000 | $4.00 | $3.00M | 16,404,017 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2023-11-20 | 2023-11-22 | 750,000 | $4.00 | $3.00M | 9,446,146 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-09-29 | 2023-10-03 | 492 | — | $0 | 2,975,170 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 864,509 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 498,510 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 432,254 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 864,509 | — | $0 | 864,509 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 498,510 | — | $0 | 1,857,706 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 494,687 | — | $0 | 1,359,196 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2023-08-31 | 2023-09-05 | 2,092 | $4.78 | $10.0K | 15,654,017 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2023-07-13 | 2023-07-17 | 21,598 | — | $0 | 15,651,925 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-06-30 | 2023-07-03 | 492 | — | $0 | 2,974,678 | SEC↗ |
| IGMS IGM Biosciences, Inc. | S Sale | 2023-06-29 | 2023-07-03 | 80,423 | $9.42 | $757.6K | 2,893,763 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2023-06-29 | 2023-07-03 | 80,423 | $9.42 | $757.6K | 2,974,186 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other | 2023-06-29 | 2023-07-03 | 54,740 | $9.42 | $515.7K | 2,919,446 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other | 2023-06-29 | 2023-07-03 | 54,740 | $9.42 | $515.7K | 2,974,186 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2023-06-26 | 2023-06-28 | 2,812,500 | $8.00 | $22.50M | 7,312,725 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 38,916,562 | — | $0 | 38,916,562 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2023-06-14 | 2023-06-16 | 53,100 | — | $0 | 53,100 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2023-05-26 | 2023-05-31 | 40,258 | — | $0 | 40,258 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | A Award | 2023-05-11 | 2023-05-15 | 494,853 | $0.25 | $123.7K | 20,344,070 | SEC↗ |
| AUGX Augmedix, Inc. | J Other | 2023-05-02 | 2023-05-04 | 7,446,146 | $3.00 | $22.34M | 15,630,327 | SEC↗ |
| AUGX Augmedix, Inc. | J Other | 2023-05-02 | 2023-05-04 | 7,446,146 | $3.00 | $22.34M | 15,630,327 | SEC↗ |
| AUGX Augmedix, Inc. | J Other | 2023-05-02 | 2023-05-04 | 5,000,000 | $3.00 | $15.00M | 0 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-04-21 | 2023-04-21 | 256,639 | $6.18 | $1.59M | 13,135,758 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-04-20 | 2023-04-21 | 20,000 | $5.99 | $119.8K | 12,879,119 | SEC↗ |
| AUGX Augmedix, Inc. | A Award deriv | 2023-04-19 | 2023-04-21 | 3,125,195 | $1.60 | $5.00M | 3,125,195 | SEC↗ |
| AUGX Augmedix, Inc. | A Award | 2023-04-19 | 2023-04-21 | 1,250,000 | $1.60 | $2.00M | 15,630,327 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 550,000 | $5.84 | $3.21M | 559,100 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 45,752 | $29.20 | $1.34M | 2,761,108 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 45,752 | $29.20 | $1.34M | 2,761,108 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 54,960 | $5.84 | $321.0K | 257,310 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 54,960 | $5.84 | $321.0K | 257,310 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other deriv | 2023-04-14 | 2023-04-17 | 550,000 | $5.84 | $3.21M | 559,100 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-04-14 | 2023-04-17 | 302,339 | $5.84 | $1.77M | 12,833,419 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2023-04-14 | 2023-04-17 | 5,492,385 | $5.84 | $32.08M | 12,833,419 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2023-04-14 | 2023-04-17 | 25,700 | $6.00 | $154.2K | 12,859,119 | SEC↗ |
| FATE FATE THERAPEUTICS INC | J Other | 2023-04-14 | 2023-04-17 | 5,492,385 | $5.84 | $32.08M | 12,833,419 | SEC↗ |
| FATE FATE THERAPEUTICS INC | C Conversion deriv | 2023-04-13 | 2023-04-17 | 33,441 | — | $0 | 2,761,108 | SEC↗ |
| FATE FATE THERAPEUTICS INC | C Conversion | 2023-04-13 | 2023-04-17 | 167,205 | — | $0 | 13,135,758 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 15,500 | — | $0 | 15,500 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2023-03-31 | 2023-04-04 | 492 | — | $0 | 3,336,999 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2023-03-09 | 2023-03-13 | 38,916,562 | $0.32 | $12.45M | 38,916,562 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-12-30 | 2023-01-04 | 230 | — | $0 | 3,336,507 | SEC↗ |
| ZYME Zymeworks Inc. | A Award | 2022-10-13 | 2022-10-17 | 30,481 | $5.03 | $153.3K | 6,075,918 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2022-10-13 | 2022-10-18 | 30,481 | $5.03 | $153.3K | 6,075,918 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other deriv | 2022-10-03 | 2022-10-05 | 16,375 | $22.48 | $368.1K | 667,666 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other deriv | 2022-10-03 | 2022-10-05 | 16,375 | $22.48 | $368.1K | 667,666 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other deriv | 2022-10-03 | 2022-10-05 | 297,801 | $22.49 | $6.70M | 4,500,225 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other deriv | 2022-10-03 | 2022-10-05 | 297,801 | $22.49 | $6.70M | 4,500,225 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other | 2022-10-03 | 2022-10-05 | 221,072 | $22.49 | $4.97M | 3,336,277 | SEC↗ |
| IGMS IGM Biosciences, Inc. | J Other | 2022-10-03 | 2022-10-05 | 221,072 | $22.49 | $4.97M | 3,336,277 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-09-30 | 2022-10-04 | 230 | — | $0 | 3,336,277 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 3,819,558 | — | $0 | 9,548,897 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 4,705,881 | — | $0 | 12,069,628 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award | 2022-07-01 | 2022-07-06 | 9,411,765 | $1.06 | $9.98M | 34,604,516 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award | 2022-07-01 | 2022-07-06 | 7,639,117 | $1.06 | $8.10M | 19,097,796 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-06-30 | 2022-07-05 | 230 | — | $0 | 3,336,047 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | J Other | 2022-06-13 | 2022-06-15 | 6,472,228 | $3.38 | $21.88M | 19,849,217 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | J Other | 2022-06-13 | 2022-06-15 | 6,472,228 | $3.38 | $21.88M | 19,849,217 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 12,968,553 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2022-06-08 | 2022-06-10 | 28,700 | — | $0 | 28,700 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 40,258 | — | $0 | 40,258 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | A Award | 2022-05-23 | 2022-05-25 | 40,983 | $3.05 | $125.0K | 19,849,217 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award deriv | 2022-04-04 | 2022-04-06 | 7,058,821 | — | $0 | 7,058,821 | SEC↗ |
| MDVL MedAvail Holdings, Inc. | A Award | 2022-04-04 | 2022-04-06 | 14,117,646 | $1.06 | $14.96M | 25,192,751 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy deriv | 2022-04-01 | 2022-04-04 | 2,608,695 | $23.00 | $60.00M | 4,500,225 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2022-03-31 | 2022-04-04 | 230 | — | $0 | 3,335,817 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2022-03-12 | 2022-03-15 | 29,497 | — | $0 | 29,497 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2021-12-31 | 2022-01-04 | 130 | — | $0 | 3,335,587 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 954,420 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 954,420 | — | $0 | 954,420 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 1,000,000 | $20.00 | $20.00M | 1,954,420 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2021-10-28 | 2023-04-21 | 1,625,000 | $4.00 | $6.50M | 6,218,238 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2021-10-28 | 2021-11-01 | 1,625,000 | $4.00 | $6.50M | 14,380,327 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | A Award deriv | 2021-10-07 | 2021-10-12 | 41,363 | — | $0 | 41,363 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | A Award | 2021-10-06 | 2021-10-08 | 14,750,786 | — | $0 | 19,750,786 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | A Award | 2021-10-06 | 2021-10-18 | 14,808,234 | — | $0 | 19,808,234 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2021-09-30 | 2021-10-04 | 130 | — | $0 | 3,426,557 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion deriv | 2021-08-10 | 2021-08-12 | 1,920,960 | — | $0 | 0 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | P Buy | 2021-08-10 | 2021-08-12 | 1,470,000 | $17.00 | $24.99M | 3,390,960 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | C Conversion | 2021-08-10 | 2021-08-12 | 1,920,960 | — | $0 | 1,920,960 | SEC↗ |
| ABSI Absci Corp | C Conversion deriv | 2021-07-26 | 2021-07-28 | 0 | — | $0 | 0 | SEC↗ |
| ABSI Absci Corp | C Conversion deriv | 2021-07-26 | 2021-07-28 | 4,209,573 | — | $0 | 0 | SEC↗ |
| ABSI Absci Corp | P Buy | 2021-07-26 | 2021-07-28 | 1,875,000 | $16.00 | $30.00M | 8,031,094 | SEC↗ |
| ABSI Absci Corp | C Conversion | 2021-07-26 | 2021-07-28 | 1,946,521 | — | $0 | 6,156,094 | SEC↗ |
| ABSI Absci Corp | C Conversion | 2021-07-26 | 2021-07-28 | 4,209,573 | — | $0 | 4,209,573 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2021-06-30 | 2021-07-02 | 130 | — | $0 | 3,426,427 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 8,208,832 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-23 | 1,050,000 | $19.00 | $19.95M | 1,936,530 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 886,530 | — | $0 | 886,530 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2021-06-19 | 2021-06-22 | 3,434 | — | $0 | 3,434 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 4,334 | — | $0 | 4,334 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-06-02 | 2021-06-04 | 2,681 | — | $0 | 12,959,903 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2021-03-31 | 2021-04-02 | 130 | — | $0 | 3,426,297 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2021-02-19 | 2021-02-23 | 6,423 | — | $0 | 6,423 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy deriv | 2021-01-08 | 2021-01-12 | 257,310 | $85.50 | $22.00M | 257,310 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2021-01-08 | 2021-01-12 | 327,485 | $85.50 | $28.00M | 12,957,222 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2020-12-31 | 2021-01-05 | 178 | — | $0 | 3,426,167 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-12-28 | 2021-02-16 | 5,863 | $5.80 | $34.0K | 1,768,718 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-12-28 | 2021-02-16 | 494,137 | $5.58 | $2.76M | 1,774,581 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2020-12-22 | 2020-12-28 | 1,286 | — | $0 | 1,286 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy deriv | 2020-12-11 | 2020-12-15 | 667,666 | $89.99 | $60.08M | 667,666 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-15 | 318,064 | — | $0 | 0 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 65,047 | $20.00 | $1.30M | 5,538,219 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 158,100 | $18.01 | $2.85M | 5,278,014 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 195,158 | $19.20 | $3.75M | 5,473,172 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 2,941,176 | $17.00 | $50.00M | 5,119,914 | SEC↗ |
| STTK Shattuck Labs, Inc. | C Conversion | 2020-10-14 | 2020-10-15 | 2,178,738 | — | $0 | 2,178,738 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 50,000 | $22.10 | $1.10M | 5,619,914 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2020-10-14 | 2020-10-15 | 31,695 | $21.09 | $668.4K | 5,569,914 | SEC↗ |
| AUGX Augmedix, Inc. | P Buy | 2020-10-05 | 2020-10-07 | 5,000,000 | $3.00 | $15.00M | 12,755,327 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2020-10-01 | 2020-10-05 | 178 | — | $0 | 3,425,989 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-09 | 2020-09-09 | 8,650 | $51.85 | $448.5K | 3,425,811 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-09 | 2020-09-09 | 14,610 | $52.96 | $773.7K | 3,417,161 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-08 | 2020-09-09 | 47,113 | $49.91 | $2.35M | 3,402,551 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 74,433 | $50.28 | $3.74M | 3,355,438 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-03 | 2020-09-03 | 74,253 | $48.69 | $3.62M | 3,281,005 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-02 | 2020-09-03 | 1,464 | $45.54 | $66.7K | 3,187,579 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-02 | 2020-09-03 | 19,173 | $46.76 | $896.5K | 3,206,752 | SEC↗ |
| IGMS IGM Biosciences, Inc. | P Buy | 2020-09-01 | 2020-09-03 | 41,759 | $44.84 | $1.87M | 3,186,115 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion deriv | 2020-08-25 | 2020-08-25 | 2,600,740 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | C Conversion | 2020-08-25 | 2020-08-25 | 1,630,660 | — | $0 | 1,630,660 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-05 | 1,226,993 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-05 | 823,371 | — | $0 | 823,371 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 1,176,470 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 14,062,719 | — | $0 | 0 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,176,470 | — | $0 | 1,176,470 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,596,222 | — | $0 | 1,596,222 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2020-07-01 | 2020-07-06 | 178 | — | $0 | 3,144,356 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 1,586,174 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 1,586,174 | — | $0 | 1,586,174 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2020-06-11 | 2020-06-17 | 1,412,928 | $28.31 | $40.00M | 12,629,737 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 13,661,202 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 1,910,657 | — | $0 | 1,910,657 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2020-04-02 | 2020-04-06 | 9,734 | $11.30 | $110.0K | 4,041,311 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-04-02 | 2020-04-06 | 38,300 | $11.36 | $435.1K | 4,050,045 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-04-02 | 2020-04-06 | 1,000 | $11.85 | $11.8K | 4,051,045 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2020-04-02 | 2020-04-06 | 100 | $11.82 | $1.2K | 4,041,211 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2020-04-01 | 2020-04-03 | 178 | — | $0 | 3,144,178 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-04-01 | 2020-04-06 | 9,000 | $11.65 | $104.8K | 4,021,579 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-04-01 | 2020-04-06 | 33,500 | $10.95 | $366.8K | 4,012,579 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2020-04-01 | 2020-04-06 | 9,634 | $11.06 | $106.6K | 4,011,945 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2020-04-01 | 2020-04-06 | 200 | $11.87 | $2.4K | 4,011,745 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-03-31 | 2020-04-06 | 22,500 | $10.18 | $229.1K | 3,971,579 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-03-31 | 2020-04-06 | 7,500 | $10.71 | $80.3K | 3,979,079 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-03-30 | 2020-04-06 | 29,800 | $9.91 | $295.3K | 3,946,379 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-03-30 | 2020-04-06 | 2,700 | $10.27 | $27.7K | 3,949,079 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | P Buy | 2020-03-27 | 2020-04-06 | 50,000 | $9.21 | $460.5K | 3,916,579 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 5,208,333 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-11 | 1,161,458 | — | $0 | 1,161,458 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2020-02-05 | 2020-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-29 | 1,044,568 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-29 | 696,378 | — | $0 | 696,378 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | U Tender deriv | 2019-10-22 | 2019-10-24 | 20,243 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 54,757 | — | $0 | 20,243 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | X Exercise deriv | 2019-10-22 | 2019-10-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | X Exercise deriv | 2019-10-22 | 2019-10-24 | 75,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | J Other deriv | 2019-10-22 | 2019-10-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | U Tender deriv | 2019-10-22 | 2019-10-24 | 779,776 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 22,500 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | D To issuer deriv | 2019-10-22 | 2019-10-24 | 30,000 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | U Tender | 2019-10-22 | 2019-10-24 | 8,244,896 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-08 | 1,164,674 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2019-10-07 | 2019-10-08 | 400,000 | $15.00 | $6.00M | 2,268,718 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-08 | 1,868,718 | — | $0 | 1,868,718 | SEC↗ |